Buyout veteran Howard Morgan discusses the state of the market through the lens of his firm’s portfolio

The W.K. Kellogg Foundation has become one of the largest philanthropic organizations in the U.S. Carlos Rangel, senior portfolio manager, discusses the Kellogg Foundation’s 20% allocation to private equity and lists his team’s “non-negotiables” when it comes to selecting managers.

U.S. manufacturing is undergoing a renaissance, and private equity firms have taken notice.

Randy Mehl of Baird Capital on how to execute smoother management transitions at smaller companies.

In part 3 of Privcap’s series on 100-day plans, the expert panel discusses how to execute changes in management without hindering the value-creation process.

Pam Hendrickson of The Riverside Company explains the broad—and underappreciated—impact of the Affordable Care Act on middle-market private equity.

MidOcean Partners Managing Director Frank Schiff gives an in-depth description of how the 100-day plan for value creation has become integral to his firm’s approach to investing.

Part two of the four-part series on how a PE firm turns a 100-day plan into a real plan for value creation.

Expert discussion of creating value in private equity with a 100-day plan. Learn how to create one and how to successfully follow through.

David Hellier, a Partner at Bertram Capital, describes his firm’s strategy of “marrying” venture capital business-building techniques with lower-middle market companies.

The right reasons to allocate to private equity secondaries, including a desire for instant portfolio diversification.

Mitchell Hollin, a Partner at Philadelphia-based LLR Partners, discusses the evolution of the lower-middle market.

How did TPG portfolio company Harrah’s Entertainment save $19 million per year on energy efficiencies? How did Carlyle portfolio company NBTY save $2 million per year on more efficient vitamin-production techniques?

The importance of an alignment of interest between the entrepreneur and the private equity sponsor in planning for an exit.

We spoke with three experts in the healthcare space to help cut through the regulatory fog and provide practical solutions to the challenge facing private equity investors

How have The Carlyle Group and TPG established their ESG programs? We learn from Bryan Corbett of The Carlyle Group, Ed Norton of TPG Capital, and Beth Lowery of TPG Capital

Gary Crittenden, Managing Partner of Huntsman Gay Global Capital, discusses what makes his firm unique in its approach to partnering with middle-market entrepreneurs.

Interview with Sachin Date, Private Equity Leader for Europe, Middle East, India and Africa at EY.